The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Reserves Based Lending redetermination completed

4 Jan 2022 07:00

RNS Number : 2518X
Igas Energy PLC
04 January 2022
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

4 January 2022

 

IGas Energy plc (AIM: IGAS)

("IGas" or "the Company")

 

Reserves Based Lending (RBL) redetermination completed

IGas is pleased to confirm it has completed its scheduled six-monthly RBL facility redetermination process.

The redetermination exercise confirms £19.3 million of debt capacity.

Cash balances at 30 November 2021 were £3.2 million with net debt of £13.4 million. 216,000 bbls are currently hedged in 2022 using swaps at an average price of $68/bbl and 114,000 bbls using puts with an average guaranteed minimum price, net of premiums, of $44/bbl. 

Commenting, CEO Stephen Bowler, said

"I am pleased that we have once again been successful in the completion of our redetermination process. Our hedge pricing is much improved in 2022 and we continue to progress opportunities to increase shareholder value through the continued diversification of the business into low-carbon energy and on our cash-generating production assets."

 

For further information please contact:

IGas Energy plc Tel: +44 (0)20 7993 9899

Stephen Bowler, Chief Executive Officer

Ann-marie Wilkinson, Director of Corporate Affairs

 

Investec Bank plc (NOMAD and Joint Corporate Broker) Tel: +44 (0)20 7597 5970

Sara Hale/Jeremy Ellis/Virginia Bull

 

Canaccord Genuity (Joint Corporate Broker) Tel: +44 (0)20 7523 8000

Henry Fitzgerald-O'Connor/James Asensio

 

Vigo Consulting Tel: +44 (0)20 7390 0230

Patrick d'Ancona/Chris McMahon/Kendall Hill

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSWESDEESELF

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.